In an age where medical innovation is reshaping lives, the Retinal Biologics Market is emerging as a beacon of hope for millions suffering from retinal diseases. With the global burden of eye disorders like age-related macular degeneration (AMD) and diabetic retinopathy reaching alarming levels, biologics are turning the tide—bringing sharper, clearer futures into focus....